logo
Experts reveal the truth about seed oils

Experts reveal the truth about seed oils

Independent5 hours ago

Influencers and some public figures claim seed oils are harmful, linking them to inflammation, obesity, and diabetes due to their Omega-6 content.
Nutritionists and dietitians dispute these claims, asserting that seed oils are healthy and a valuable source of polyunsaturated fatty acids.
A study in JAMA Internal Medicine indicated that higher consumption of plant oils, including seed oils, was associated with a reduced risk of death from cancer and cardiovascular disease.
Experts clarify that health concerns often attributed to seed oils in processed foods are more accurately due to the combination of high saturated fat, sodium, and added sugar in those products.
They advise focusing on replacing saturated fats like butter with unsaturated fats found in seed oils to improve health outcomes, as Omega-6 is not inherently inflammatory and is essential.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Low start dose of Amgen experimental weight-loss drug limits side effects
Low start dose of Amgen experimental weight-loss drug limits side effects

Reuters

time35 minutes ago

  • Reuters

Low start dose of Amgen experimental weight-loss drug limits side effects

June 23 (Reuters) - People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given high doses but with milder side effects, according to full results of a mid-stage trial presented at a medical meeting on Monday. As a result, Amgen (AMGN.O), opens new tab said its recently launched 72-week Phase 3 trial will randomize obese or overweight adults to three different doses, with each group started at a much lower dose that will be increased over an eight-week period. "MariTide is a long-acting drug, but side effects are short-lived, which is a great learning and gives us confidence to go into Phase 3," Jay Bradner, executive vice president of research and development at Amgen, told Reuters. The company previously announced top-line results from the year-long Phase 2 trial showing that MariTide, injected monthly or every other month, helped overweight or obese patients shed up to 20% of their body weight. The full results were presented at the American Diabetes Association meeting in Chicago and published in the New England Journal of Medicine. The data show that for people with type 2 diabetes, MariTide lowered blood sugar by up to 2.2 percentage points. Amgen said weight loss with MariTide also improved pre-specified cardiometabolic measures, including waist circumference, blood pressure, inflammation markers and blood lipids. MariTide is an antibody linked to a pair of peptides that activates receptors for the appetite- and blood sugar-reducing hormone GLP-1 while simultaneously blocking a second gut hormone called GIP. Amgen said no new safety signals were identified in the study and tolerability was consistent with the GLP-1 class, which is associated with gastrointestinal side effects such as nausea. In late-stage trials, Novo Nordisk's ( opens new tab GLP-1 obesity drug Wegovy had a vomiting rate of 24%, while Eli Lilly's (LLY.N), opens new tab Zepbound, which is designed to activate both GLP-1 and GIP, had a rate of 13%. Each of those drugs are given as weekly injections. In the mid-stage MariTide study, vomiting was reported by nearly 90% of patients started at the highest tested dose, compared with 50% of patients ramped up to a full dose in one step and 22% of those brought to their target dose over eight weeks. Amgen said trial discontinuation rates due to gastrointestinal issues of up to 7.8% were lower for groups treated with escalating doses. The company said it plans to start additional Phase 3 studies this year for MariTide in patients with a variety of serious health issues, including cardiovascular disease caused by clogging arteries, heart failure, and obstructive sleep apnea.

Just one serving of a favorite summer food raises risk of contracting super bacteria resistant to treatments
Just one serving of a favorite summer food raises risk of contracting super bacteria resistant to treatments

Daily Mail​

time41 minutes ago

  • Daily Mail​

Just one serving of a favorite summer food raises risk of contracting super bacteria resistant to treatments

People indulging in a shrimp cocktail or seafood salad this summer could be at risk of potentially fatal antibiotic-resistant infections, scientists warn. Researchers in Georgia have found that seafood favorites like shellfish and scallops imported into the US may be contaminated with bacteria that is resistant to colistin, a 'last-resort' medication used to kill bacteria that isn't cleared by other treatments. And consuming the seafood could lead to the gastrointestinal tract being colonized by the bacteria, experts suggest, which could wait for the immune system to weaken before causing a deadly infection. It's not known exactly how many strains of bacteria are resistant the drug, but experts are worried that the number is growing amid widespread overuse of antibiotics, allowing bacteria to mutate and become better at evading treatments. Colistin is only used when standard treatments have failed — typically against pneumonia or sepsis, a life-threatening blood infection. Scientists have long voiced concern about rising drug resistance, warning it could turn previously treatable infections into life-threatening diseases. Lead researcher Issmat Kassem, a microbiologist, warned: 'We love our seafood. [But] if you go out to lunch today, your plate might have ingredients from six, seven, eight countries. 'Some countries do not have strict regulations for using antibiotics in food animal production, so imported food can be a vehicle for transmission of resistance.' Colistin was first discovered in the 1950s but doctors stopped using it by the 1980s because it was revealed patients using the drug were found to suffer from damage to the nerves and kidneys. However, a rise in drug-resistant infections in the 1990s saw use of the medication increase as there was a need for new treatments. Data online suggests that colistin is currently administered to fewer than 1,000 seriously ill patients in the US every year, although this number continues to rise. For the study, researchers tested shrimp and scallops bought from eight seafood markets in Atlanta, Georgia. The team tested samples for the colistin-resistance genes known as mcr. At least 10 types of mcr genes have now been identified, with scientists warning they might spread though imported and exported food. It wasn't clear how the resistant bacteria had ended up on seafood, but previous research has suggested this may happen if rainwater falls on farms and then flows into the waters where the fish or crustaceans are being farmed. More than 90 percent of seafood consumed in the US is imported, with major sellers including China, Norway, Ecuador, Chile and India. The food is screened for numerous contaminants, like mercury, PFAS and antibiotics, but is not checked for antibiotic-resistant bacteria. And each country has varying regulations when it comes to collecting, storing, slaughtering and exporting or importing goods for consumption. In some countries, farm animals, including farmed seafood, may be treated with colistin, which studies show may marginally boost their growth rates. A 2023 study suggested that despite concerns over resistance, the antibiotic was still being widely used for feed in some low- and middle-income countries. It is also given sometimes to prevent outbreaks because of the unsanitary conditions some animals are kept in. It was not clear what the name of the colistin-resistant bacteria was, or which countries the imported seafood had come from. The findings were revealed in a presentation for ASM Microbiome 2025 in Los Angeles, the annual meeting of the American Society for Microbiology. It is set to be published as a study in the journal mSphere. The scientists cautioned that their study focused on just one food group, but said it was likely that others also posed a risk. The team added that the drug-resistant bacteria they found on the seafood matched a strain they had also detected in wastewater in the city, suggesting the bacteria was spreading in the community. Antibiotic resistant bacteria are a growing risk in America, with more than 2.8million infections now recorded every year — and with treatment costs having more than doubled since 2002. Around 35,000 people die from antibiotic-resistant infections in the US every year. While much of seafood is consumed raw in the summer, people can reduce their risk by cooking the food, which likely kills the resistant bacteria. But Americans should be extra vigilant as the bacteria can still be spread onto the surface food is prepared on — raising the risk of infection. Older individuals and pregnant women are already advised not to eat raw seafood, especially sushi, which can put them at a higher risk of infection because of their weakened immune systems.

Katie Price reveals exactly how much she weighs after fan concerns over her skinny frame
Katie Price reveals exactly how much she weighs after fan concerns over her skinny frame

The Sun

timean hour ago

  • The Sun

Katie Price reveals exactly how much she weighs after fan concerns over her skinny frame

KATIE Price has revealed exactly how much she weighs following fan concerns over her skinny frame. Former glamour model Katie, 47, who first sparked worry over her shrinking appearance at the start of the year, hit out at critics on Snapchat as she zoomed in on a set of scales. 5 5 The TV personality, believed to be 5ft 4in tall, showed her weight as 7st 12lb. Katie had attempted to put fears to rest, saying in the video: "Everyone is so obsessed with my weight. This is what I weigh. That. That is what I weigh." But with the combined weight of her 2120cc breast implants removed - which are thought to weigh around 4.87lb each - her implant-free body is closer to 7st 2lb. That puts her BMI at 17.2, putting her below the healthy range and into the underweight category (below 18.5). It also nudges her dangerously close to being classed as moderately underweight, a sub-category defined by the World Health Organization as a BMI below 17. Katie has also confessed to having dermal filler injected into her face and bum, however the weight of these treatments are unknown in her case. The podcaster previously tried to shut down fears over her weight loss, saying she decided to slim down after a long-standing foot injury and attempts at IVF made her put on weight. Speaking on her Snapchat in May, Katie said: "Yes I've lost weight. "Yes that what I've wanted to do, I've wanted to lose weight. "Because the past three, four years ago when I broke my feet and I was in a wheelchair for 10 months because they said I'd never walk again, and obviously you put weight on being in a wheelchair. Katie Price shows off biggest ever boob job in sheer lace crop top in Ibiza "And then I did all the IVF stuff, that also puts on weight. "So yeah I did put on weight and I hated it, I felt uncomfortable and it wasn't me." She then explained how, after finishing her failed IVF treatment, she became more active with healthy eating. "Everyone is talking about it - it's driving me mad," she said. "I'm healthy and I do eat. "If you look at old old pictures of me in the Jordan days, I was always skinny. "But today where I have lost weight, I feel, my butt looks like a deflated balloon." Some fans have asked Katie whether she has taken popular weight loss jabs to shed the pounds - but the star, who has been open in the past about procedures she's gone through, has strongly denied it. 5 5 5

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store